Lpl Financial LLC Vbi Vaccines Inc Transaction History

Lpl Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.29 - $0.64 $5,888 - $12,995	20,306 Added 14.02%	165,113 $49,000
Q4 2022 Feb 07, 2023	SELL	$0.38 - $22.5 $725 - $42,952	-1,909 Reduced 1.3%	144,807 $56,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $15,400 - $493,669	-21,097 Reduced 12.57%	146,716 $104,000
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.81 $50 - $139	-77 Reduced 0.05%	167,813 $136,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $87,837 - $170,832	69,163 Added 70.05%	167,890 $279,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $306,531 - $446,620	-138,702 Reduced 58.42%	98,727 $231,000
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $11,838 - $15,728	4,228 Added 1.81%	237,429 $738,000
Q2 2021 Aug 13, 2021	BUY	$2.61 - $4.17 $80,367 - $128,402	30,792 Added 15.21%	233,201 $781,000
Q1 2021 May 14, 2021	BUY	$2.91 - $4.32 $447,287 - $664,014	153,707 Added 315.61%	202,409 $629,000
Q4 2020 Feb 12, 2021	BUY	$2.15 - $3.5 $104,709 - $170,457	48,702 New	48,702 $134,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.